通用肺上皮DNA甲基化标志物用于液体活检检测肺损伤
研究通过全基因组亚硫酸氢盐测序获取人肺泡和支气管上皮细胞甲基化组,开发了检测17个位点甲基化状态的PCR测序方法,用于评估健康志愿者和肺病患者血浆中肺来源cfDNA。结果显示晚期肺癌患者血中肺cfDNA浓度大幅升高,COPD急性加重患者较稳定期升高且与未来加重和死亡相关,提示通用cfDNA甲基化标志物可灵敏特异地检测肺损伤。
要点
- 肺上皮特异性DNA甲基化标志物可检测血浆中肺来源cfDNA,反映肺细胞死亡。
- 晚期肺癌患者血中肺cfDNA浓度大幅升高,其他肺病亦可见但程度较低。
- COPD急性加重患者肺cfDNA较稳定期升高,且与未来加重和死亡相关。
核心结论
- 正常肺上皮的通用cfDNA甲基化标志物可实现不依赖突变的灵敏特异的肺来源cfDNA检测,反映正在发生的肺损伤。
研究设计与样本
- 从手术标本分选人肺泡和支气管上皮细胞,用全基因组亚硫酸氢盐测序获取甲基化组。
- 开发PCR测序法检测17个具有肺特异性甲基化模式的位点。
- 在健康志愿者和肺病患者血浆中评估肺来源cfDNA。
主要发现
- 在肺泡或支气管上皮细胞中独特未甲基化的位点富集控制肺特异性基因的增强子。
- 正常肺细胞更新可能将cfDNA释放到气道而非血液。
- 晚期肺癌患者血中肺cfDNA浓度大幅升高。
- 接受支气管镜检查者中, later诊断为肺癌者血浆可检出肺来源cfDNA,其他肺病者程度较低。
- COPD急性加重患者肺cfDNA较稳定期升高,且与未来加重和死亡相关。
临床怎么用
- 通用cfDNA甲基化标志物可用于液体活检,不依赖突变检测肺来源cfDNA并反映ongoing肺损伤。
- 在COPD患者中检测肺cfDNA可能帮助评估急性加重风险及预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Circulating biomarkers for lung damage are lacking. Lung epithelium-specific DNA methylation patterns can potentially report the presence of lung-derived cell-free DNA (cfDNA) in blood, as an indication of lung cell death. METHODS: We sorted human lung alveolar and bronchial epithelial cells from surgical specimens, and obtained their methylomes using whole-genome bisulfite sequencing. We developed a PCR sequencing assay determining the methylation status of 17 loci with lung-specific methylation patterns, and used it to assess lung-derived cfDNA in the plasma of healthy volunteers and patients with lung disease. RESULTS: Loci that are uniquely unmethylated in alveolar or bronchial epithelial cells are enriched for enhancers controlling lung-specific genes. Methylation markers extracted from these methylomes revealed that normal lung cell turnover probably releases cfDNA into the air spaces, rather than to blood. People with advanced lung cancer show a massive elevation of lung cfDNA concentration in blood. Among individuals undergoing bronchoscopy, lung-derived cfDNA is observed in the plasma of those later diagnosed with lung cancer, and to a lesser extent in those diagnosed with other lung diseases. Lung cfDNA is also elevated in patients with acute exacerbation of COPD compared with patients with stable disease, and is associated with future exacerbation and mortality in these patients. CONCLUSIONS: Universal cfDNA methylation markers of normal lung epithelium allow for mutation-independent, sensitive and specific detection of lung-derived cfDNA, reporting on ongoing lung injury. Such markers can find broad utility in the study of normal and pathologic human lung dynamics.
引用
- Magenheim J, Rokach A, Peretz A, et al. Universal lung epithelium DNA methylation markers for detection of lung damage in liquid biopsies. Eur Respir J. 2022. PMID: 35450968. doi:10.1183/13993003.03056-2021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。